University of New South Wales

An Australian team has sequenced some 4,000 healthy individuals over 70 years old for the Medical Genome Reference Bank database.

The tool uses magnetic, gold-coated electrodes to detect microRNA in blood within a concentration range of 10 attomolar to 1 nanomolar in 30 minutes.

Researchers profiling pancreatic neuroendocrine tumors detected inherited cancer-related mutations in nearly one-fifth of affected individuals.

Pharmacy chain Walgreens seeks to terminate its relationship with Theranos, and may be exploring one with 23andMe.

Scientists found that extinctions of many species during the last glacial period coincided with periods of rapid warming.

The new assay uses high-resolution melt curve analysis to detect variations in genes that lead some people to spontaneously clear hepatitis C viral infections.

After receiving ISO certification and publishing studies on its technology in 2014, the Australian MDx firm is targeting a launch of its meningitis test in 2015.

NEW YORK (GenomeWeb News) – Benitec Biopharma today announced a licensing agreement with the University of New South Wales for use of the university's RNAi technology and to develop a companion diagnostic to identify patients who may develop resistance to chemotherapy.

NEW YORK (GenomeWeb News) – Griffith University in Australia announced on Tuesday a collaboration to sequence DNA from ancient human remains to determine the origins of populations from Southeast Asian and Australia.

American, African, and Australian researchers reported today that the have sequenced the complete genomes of two individuals from southern Africa, one of whom is Archbishop Desmond Tutu, and the exomes of three others.

Pages

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.